Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014, Article ID 213631, 3 pages
http://dx.doi.org/10.1155/2014/213631
Case Report

Successful Outcome of Chronic Intrahepatic Cholestasis in an Adult Patient with Sickle Cell/β+ Thalassemia

1Adults Thalassemia Unit, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Konstantinoupoleos 49, 54642 Thessaloniki, Greece
2Department of Gastroenterology, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Konstantinoupoleos 49, 54642 Thessaloniki, Greece

Received 1 December 2013; Accepted 30 December 2013; Published 9 February 2014

Academic Editors: U. Dasgupta, K. Konstantopoulos, F. Kutlar, and M.-C. Kyrtsonis

Copyright © 2014 Efthymia Vlachaki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Vlachaki, M. Mainou, E. Bekiari, E. Vetsiou, and A. Tsapas, “Safety and efficacy of 4 years of deferasirox treatment for sickle cell disease patients,” Hemoglobin, vol. 37, no. 1, pp. 94–100, 2013. View at Publisher · View at Google Scholar
  2. D. B. Costa, R. A. Miksad, M. S. Buff, Y. Wang, and B. J. Dezube, “Case of fatal sickle cell intrahepatic cholestasis despite use of exchange transfusion in an African-American patient,” Journal of the National Medical Association, vol. 98, no. 7, pp. 1183–1187, 2006. View at Google Scholar · View at Scopus
  3. W. E. Norris, “Acute hepatic sequestration in sickle cell disease,” Journal of the National Medical Association, vol. 96, no. 9, pp. 1235–1239, 2004. View at Google Scholar · View at Scopus
  4. N. Zakaria, A. Knisely, B. Portmann et al., “Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy,” Blood, vol. 101, no. 1, pp. 101–103, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Chehal, A. Taher, and A. Shamseddine, “Sicklemia with multi-organ failure syndrome and thrombotic thrombocytopenic purpura,” Hemoglobin, vol. 26, no. 4, pp. 345–351, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. A. O'Callaghan, S. G. O'Brien, M. Ninkovic et al., “Chronic intrahepatic cholestasis in sickle cell disease requiring exchange transfusion,” Gut, vol. 37, no. 1, pp. 144–147, 1995. View at Google Scholar · View at Scopus
  7. P. A. Berry, T. J. S. Cross, S. L. Thein et al., “Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment,” Clinical Gastroenterology and Hepatology, vol. 5, no. 12, pp. 1469–1476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. M. R. Jeng, M. D. Rieman, P. E. Naidu et al., “Resolution of chronic hepatic sequestration in a patient with homozygous sickle cell disease receiving hydroxyurea,” Journal of Pediatric Hematology/Oncology, vol. 25, no. 3, pp. 257–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. C. S. R. Hatton, C. Bunch, and D. J. Weatherall, “Hepatic sequestration in sickle cell anaemia,” British Medical Journal, vol. 290, no. 6470, pp. 744–745, 1985. View at Google Scholar · View at Scopus
  10. C. Tafrali, A. Paizi, J. Borg et al., “Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy,” Pharmacogenomics, vol. 14, no. 5, pp. 469–483, 2013. View at Publisher · View at Google Scholar
  11. R. E. Ware, “How I use hydroxyurea to treat young patients with sickle cell anemia,” Blood, vol. 115, no. 26, pp. 5300–5311, 2010. View at Publisher · View at Google Scholar · View at Scopus